Heather Gray-Edwards discusses Next Generation CNS Delivery at the 3rd Annual Gene Therapy for Neurological Disorders this week in Boston. EnClear Therapies is proud to partner with Dr. Edwards and UMass Chan Medical School. Utilizing EnClear’s CSF health platform to provide precision delivery to areas of the CNS most benefited by both existing and next-generation therapeutics, while reducing side effects and peripheral toxicity.